PFE position history
The shares of Pfizer (PFE) that Murphy Pohlad Asset Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 103,279 shares, $4.4M, 1.8% of portfolio
- 2021 Q4: 103,179 shares, $6.1M, 2.4% of portfolio, Reduce −0.1%
- 2022 Q1: 106,129 shares, $5.5M, 2.2% of portfolio, Add +2.9%
- 2022 Q2: 107,709 shares, $5.6M, 2.5% of portfolio, Add +1.5%
- 2022 Q3: 109,807 shares, $4.8M, 2.2% of portfolio, Add +1.9%
- 2022 Q4: 110,849 shares, $5.7M, 2.3% of portfolio, Add +0.9%
- 2023 Q1: 111,114 shares, $4.5M, 1.9% of portfolio, Add +0.2%
- 2023 Q2: 116,564 shares, $4.3M, 1.8% of portfolio, Add +4.9%
- 2023 Q3: 126,979 shares, $4.2M, 1.8% of portfolio, Add +8.9%
- 2023 Q4: 128,829 shares, $3.7M, 1.5% of portfolio, Add +1.5%
- 2024 Q1: 127,624 shares, $3.5M, 1.4% of portfolio, Reduce −0.9%
- 2024 Q2: 133,624 shares, $3.7M, 1.6% of portfolio, Add +4.7%
- 2024 Q3: 146,269 shares, $4.2M, 1.8% of portfolio, Add +9.5%
- 2024 Q4: 115,225 shares, $3.1M, 1.3% of portfolio, Reduce −21.2%
- 2025 Q1: 123,965 shares, $3.1M, 1.3% of portfolio, Add +7.6%
- 2025 Q2: 116,895 shares, $2.8M, 1.2% of portfolio, Reduce −5.7%
- 2025 Q3: 82,436 shares, $2.1M, 0.82% of portfolio, Reduce −29.5%
- 2025 Q4: 62,795 shares, $1.6M, 0.60% of portfolio, Reduce −23.8%
- 2026 Q1: 57,937 shares, $1.6M, 0.58% of portfolio, Reduce −7.7%
- 2026 Q2: 52,377 shares, $1.3M, 0.44% of portfolio, Reduce −9.6%
- 2026 Q3: 54,032 shares, $1.5M, 0.54% of portfolio, Add +3.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|